Mostrar el registro sencillo del ítem

dc.contributor.author
Reynoso, Rita Paola  
dc.contributor.author
Laufer, Natalia Lorna  
dc.contributor.author
Hackl, Matthias  
dc.contributor.author
Skalicky, Susanna  
dc.contributor.author
Monteforte, Rossella  
dc.contributor.author
Turk, Gabriela Julia Ana  
dc.contributor.author
Carobene, Mauricio  
dc.contributor.author
Quarleri, Jorge Fabian  
dc.contributor.author
Cahn, Pedro  
dc.contributor.author
Werner, Roland  
dc.contributor.author
Stoiber, Heribert  
dc.contributor.author
Grillari Voglauer, Regina  
dc.contributor.author
Grillari, Johannes  
dc.date.available
2020-09-03T18:29:18Z  
dc.date.issued
2014-08  
dc.identifier.citation
Reynoso, Rita Paola; Laufer, Natalia Lorna; Hackl, Matthias; Skalicky, Susanna; Monteforte, Rossella; et al.; MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro; Nature Publishing Group; Scientific Reports; 4; 5915; 8-2014; 1-9  
dc.identifier.issn
2045-2322  
dc.identifier.uri
http://hdl.handle.net/11336/113155  
dc.description.abstract
Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite controllers and chronically infected individuals and compared against healthy donors. Several miRNAs correlate with CD41 T cell count or with the known time of infection. No significant differences were observed between elite controllers and healthy donors; however, 16 miRNAs were different in the plasma of chronic infected versus healthy donors. In addition, levels of hsa-miR-29b-3p, hsa-miR-33a-5p and hsa-miR-146a-5p were higher in plasma from elite controllers than chronic infected and hsa-miR-29b-3p and hsa-miR-33a-5p overexpression significantly reduced the viral production in MT2 and primary T CD41 cells. Therefore, levels of circulating miRNAs might be of diagnostic and/or prognostic value for HIV infection, and hsa-miR-29b-3p and miR-33a-5p may contribute to the design of new anti-HIV drugs.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Nature Publishing Group  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
HIV  
dc.subject
ELITE CONTROLLERS  
dc.subject
MICRORNA  
dc.subject.classification
Virología  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-07-21T20:19:08Z  
dc.journal.volume
4  
dc.journal.number
5915  
dc.journal.pagination
1-9  
dc.journal.pais
Reino Unido  
dc.description.fil
Fil: Reynoso, Rita Paola. University of Natural Resources and Life Sciences; Austria  
dc.description.fil
Fil: Laufer, Natalia Lorna. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Hackl, Matthias. University of Natural Resources and Life Sciences; Austria. Tamirna Gmbh; Austria  
dc.description.fil
Fil: Skalicky, Susanna. Evercyte Gmbh; Austria  
dc.description.fil
Fil: Monteforte, Rossella. University of Natural Resources and Life Sciences; Austria  
dc.description.fil
Fil: Turk, Gabriela Julia Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Carobene, Mauricio. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina  
dc.description.fil
Fil: Quarleri, Jorge Fabian. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina  
dc.description.fil
Fil: Cahn, Pedro. Fundación Huésped; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina  
dc.description.fil
Fil: Werner, Roland. Medizinische Universitat Innsbruck; Austria  
dc.description.fil
Fil: Stoiber, Heribert. Medizinische Univesitat Innsbruck; Austria  
dc.description.fil
Fil: Grillari Voglauer, Regina. University of Natural Resources and Life Sciences; Austria. Evercyte Gmbh; Austria  
dc.description.fil
Fil: Grillari, Johannes. University of Natural Resources and Life Sciences; Austria. Evercyte Gmbh; Austria  
dc.journal.title
Scientific Reports  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.nature.com/srep/2014/140801/srep05915/full/srep05915.html  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1038/srep05915